Most-used short-read sequencers ranked by how many preprints say they used each

Short-read sequencers read DNA a few hundred bases at a time, accurately and cheaply. Most genome, exome and single-cell data comes from them. Updated daily (as of Nov 16)

Illumina NovaSeq X is the most-used short-read sequencer.

Illumina NovaSeq X had 44% of the uses in Jun–Nov 2026, up from 33% the year before. Illumina NextSeq is second with 40%.

#PlatformLast 6 monthsGrowthTotalBy year
1 NovaSeq XIllumina 1,309 preprints +47% 3,525 38%
2 NextSeqIllumina 1,169 preprints −19% 4,385 47%
3 DNBSEQMGI 296 preprints +6% 946 10%
4 AVITIElement Biosciences 171 preprints +50% 447 5%

Last 6 months is Jun–Nov 2026. Growth compares it with Jun–Nov 2025, as a share of all preprints. Total counts every preprint since April 2025 that says it used the platform.

Top institutions for each platform

  1. Stanford University92
  2. University of California, San Francisco61
  3. University of California, Los Angeles53
  4. University of California, San Diego51
  5. Johns Hopkins University48
  1. University of Washington61
  2. Stanford University54
  3. University of Pennsylvania48
  4. Institut Pasteur48
  5. University of Pittsburgh40
  1. The University of Tokyo16
  2. Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences15
  3. Aarhus University12
  4. BGI Research12
  5. Peking University11

Counts every preprint since April 2025, by the corresponding author's institution.

Element AVITI is growing fastest.

Up 50% in Jun–Nov 2026 vs the previous year as a share of all preprints. Illumina NovaSeq X was up 47%, MGI DNBSEQ up 6% and Illumina NextSeq down 19%. All four together grew 8%. Compare side by side: AVITI vs NovaSeq X →

NovaSeq XNextSeqDNBSEQAVITI

Latest preprints using short-read sequencing

How we count which preprints use each platform

An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.

Want to reach out to the labs using each product?

Get the PIs behind the preprints: institutions, labs, platforms they used, and how to reach them.

Institutions with the most preprints using these platforms